Bellevue Group AG reduced its position in shares of Cigna Corporation (NYSE:CI) by 12.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 33,000 shares of the health services provider’s stock after selling 4,722 shares during the period. Bellevue Group AG’s holdings in Cigna Corporation were worth $4,834,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Bronfman E.L. Rothschild L.P. increased its position in shares of Cigna Corporation by 1.1% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock worth $309,000 after buying an additional 22 shares in the last quarter. Boys Arnold & Co. Inc. boosted its stake in Cigna Corporation by 1.8% in the first quarter. Boys Arnold & Co. Inc. now owns 1,833 shares of the health services provider’s stock worth $269,000 after buying an additional 33 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its stake in Cigna Corporation by 1.1% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,611 shares of the health services provider’s stock worth $485,000 after buying an additional 39 shares during the last quarter. IFP Advisors Inc boosted its stake in Cigna Corporation by 1.9% in the first quarter. IFP Advisors Inc now owns 2,180 shares of the health services provider’s stock worth $319,000 after buying an additional 41 shares during the last quarter. Finally, Harvest Capital Management Inc boosted its stake in Cigna Corporation by 2.5% in the first quarter. Harvest Capital Management Inc now owns 2,245 shares of the health services provider’s stock worth $329,000 after buying an additional 55 shares during the last quarter. Institutional investors and hedge funds own 86.89% of the company’s stock.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Shares of Cigna Corporation (NYSE:CI) traded down 0.31% during mid-day trading on Tuesday, reaching $169.74. The company’s stock had a trading volume of 298,640 shares. The stock has a market capitalization of $43.46 billion, a price-to-earnings ratio of 22.66 and a beta of 0.44. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $170.56. The company’s 50-day moving average is $162.87 and its 200-day moving average is $150.43.

Cigna Corporation (NYSE:CI) last announced its earnings results on Friday, May 5th. The health services provider reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.33. Cigna Corporation had a net margin of 6.53% and a return on equity of 16.07%. The business had revenue of $10.39 billion during the quarter, compared to the consensus estimate of $10.11 billion. During the same quarter in the prior year, the firm earned $2.46 earnings per share. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. Equities analysts predict that Cigna Corporation will post $9.73 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.dailypolitical.com/2017/06/20/bellevue-group-ag-has-4-83-million-stake-in-cigna-corporation-ci.html.

A number of analysts have recently weighed in on CI shares. Zacks Investment Research cut Cigna Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, April 5th. Bank of America Corporation started coverage on Cigna Corporation in a research report on Monday, March 13th. They issued a “buy” rating and a $175.00 price objective for the company. They noted that the move was a valuation call. Deutsche Bank AG started coverage on Cigna Corporation in a research report on Wednesday, April 5th. They issued a “buy” rating and a $172.00 price objective for the company. Jefferies Group LLC reissued a “buy” rating and issued a $178.00 price objective (up previously from $172.00) on shares of Cigna Corporation in a research report on Sunday, April 23rd. Finally, Stifel Nicolaus raised their price objective on Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, May 5th. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $172.89.

In other news, insider Jason D. Sadler sold 4,213 shares of the stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $152.01, for a total transaction of $640,418.13. Following the completion of the sale, the insider now owns 36,231 shares in the company, valued at $5,507,474.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Mary T. Hoeltzel sold 500 shares of the stock in a transaction dated Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total transaction of $83,350.00. Following the sale, the vice president now owns 2,449 shares of the company’s stock, valued at approximately $408,248.30. The disclosure for this sale can be found here. Insiders have sold 46,246 shares of company stock valued at $7,433,839 in the last quarter. Insiders own 1.30% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.